Dr. Haemel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero St
3rd Floor
San Francisco, CA 94115Phone+1 415-353-7800Fax+1 415-353-7870
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine/Dermatology, 2006 - 2011
- The Warren Alpert Medical School of Brown UniversityClass of 2006
Certifications & Licensure
- CA State Medical License 2011 - 2027
- WI State Medical License 2008 - 2021
- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Fracture risk in linear morphea-affected limbs: A pilot retrospective study of adult patients.Maha Kazmi, Katharina Shaw, Winnie Fan, Bianca Obiakor, Ruth Ann Vleugels
JAAD International. 2025-02-01 - Direct Immunofluorescence in Dermatomyositis and Lupus Erythematosus: Cross-Sectional Diagnostic Accuracy and Correlation With Serologies and Other Features of Systemi...Rebecca Jacobson, Maha Kazmi, Heidi Vaughan, Ritesh Agnihothri, Jeffrey P North
The American Journal of Dermatopathology. 2024-12-31 - Optimizing Diagnostic Test Accuracy of Skin Tissue Assays in Cutaneous Invasive Fungal Disease.Richard W Kim, Rodrigo A Gutierrez, Rebecca Jacobson, Jennifer M Babik, Monica Fung
Journal of the American Academy of Dermatology. 2024-10-22
Journal Articles
- Telangiectases in Systemic SclerosisRitesh Agnihothri, Anna Haemel, JAMA Dermatology
- At the Leading Edge in Morphea—New Insights into Disease Course and Management OptionsCarla N Cruz-Diaz, Anna K Haemel, JAMA Dermatology
Press Mentions
- Functional and Cutaneous Treatment Outcomes with Intravenous Immunoglobulin for Eosinophilic Fasciitis: A Retrospective StudyMarch 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: